Keeping up with the Molecular Targets in the Treatment of Advanced Non-Small Cell Lung Cancer
Nurses and other health care providers need to be familiar with the new approved agents (and their corresponding molecular biomarkers) and side effects associated with the newer agents, so they can improve care for their patients.
Communicating Within the Interdisciplinary Care Team for NSCLC

This module will feature members of the NSCLC care team presenting best practice protocols for integrating biomarker testing and discussing practical challenges such as timing, sequencing versus broad panel testing, and the roles of the interdisciplinary team.

Communicating Within the Interdisciplinary Care Team for NSCLC

This module will feature members of the NSCLC care team presenting best practice protocols for integrating biomarker testing and discussing practical challenges such as timing, sequencing versus broad panel testing, and the roles of the interdisciplinary team.

Implications of Biomarker Testing in the Era of Targeted NSCLC Therapies
This module will present current and new clinical data of targeted therapies and how this information translates into personalized medicine and the development of individualized treatment plans for patients with NSCLC based on expression of biomarkers.
Implications of Biomarker Testing in the Era of Targeted NSCLC Therapies
This module will present current and new clinical data of targeted therapies and how this information translates into personalized medicine and the development of individualized treatment plans for patients with NSCLC based on expression of biomarkers.
Tissue Acquisition and Analysis

This module will include a review of guidelines, tissue acquisition and sample preparation, differentiating assays, specific biomarker types and subtypes, molecular and cytopathology evaluation, and tips on how to interpret lab results.

Tissue Acquisition and Analysis

This module will include a review of guidelines, tissue acquisition and sample preparation, differentiating assays, specific biomarker types and subtypes, molecular and cytopathology evaluation, and tips on how to interpret lab results.

Accurate Diagnosis and Personalized Treatment of NSCLC for the Interdisciplinary Team
It is essential that all members of the NSCLC care team understand the necessary processes and are equipped to apply current research on genomic targets to testing for mutations/drivers in appropriate advanced NSCLC patients.
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer
This tumor board will discuss how to select the most appropriate therapy for patients with lung cancer using a case-based format.
NCCN Guidelines® Insights - Non–Small Cell Lung Cancer, Version 2.2021
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.

Pages

Subscribe to RSS - Lung Cancers